FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

427292001: Insulin aspart protamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661317015 Insulin aspart protamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673417010 Insulin aspart protamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488093016 Insulin aspart protamine crystallised en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488094010 Insulin aspart protamine crystallized en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2661317015 Insulin aspart protamine (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2661317015 Insulin aspart protamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673417010 Insulin aspart protamine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2673417010 Insulin aspart protamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488093016 Insulin aspart protamine crystallised en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488094010 Insulin aspart protamine crystallized en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
25201000188116 insuline aspart recombinante fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817921000172118 insuline aspart fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
25201000188116 insuline aspart recombinante fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817921000172118 insuline aspart fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin aspart protamine Is a insulina aspartat false Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart protamine Has disposition Pancreatic hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart protamine Is a Short-acting insulin false Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart protamine Is modification of (attribute) insulina aspartat false Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart protamine Is a Human insulin (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart protamine Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start